• SENSEX 71,593.24
    -1,045.46 (--1.44%)
  • BANKNIFTY 54,515.05
    -540.50 (--0.98%)
  • ITC
    253.15 253.15(%)
  • Kanohar Elect.
    1,210.00 1,210.00(%)
  • Axis Bank
    1,257.00 1,418.30(%)
  • NSE
    1,717.00 1,712.00(%)
  • ICICI Bank
    1,340.00 1,187.55(%)
  • Moneyview
    55.62 48.33(%)
  • Reliance Industries
    1,173.00 1,161.00(%)
  • LIC Housing Fin.
    547.50 598.00(%)
  • Cupid
    357.45 357.45(%)
  • HDFC Bank
    690.65 682.00(%)
  • One 97
    1,560.60 947.10(%)
  • Larsen & Toubro
    3,606.10 3,288.65(%)
  • Bharti Airtel
    1,790.35 1,726.05(%)
  • Titan Company
    4,364.00 3,470.60(%)
  • TCS
    2,059.40 1,976.00(%)
  • Petronet LNG
    288.00 235.45(%)
  • United Spirits
    1,308.10 1,210.40(%)
  • Senco Gold
    359.00 430.00(%)
  • Jindal Steel
    1,002.00 978.20(%)
  • Kotak Mah. Bank
    433.05 345.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Bharat Parenterals Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 3882.0
  • ISIN : INE365Y01019
1,892.80 12 (0.62%)
  • As on 08 Oct 2026 (EOD)

  • Today’s Low

    1,850.00

  • Today’s High

    1,938.70

  • Open

    1,899.60

  • Perv Close

    1,881.20

  • 52W Low

    1,125.70

  • 52W High

    2,277.60

Key Indicators

  • P/E(TTM)

    135.66

  • Mar.Cap (₹Cr.)

    1,304.51

  • Div & Yield %

    0.05

  • Book Value(₹)

    583.79

  • Debt-Equity Ratio

    0.62

  • AGM Date

    08-Oct-2026

  • EPS

    14.04

  • P/E Ratio

    135.66

Financials Ratios

  • Debt-Equity Ratio

    0.55

  • Mar.Cap (₹Cr.)

    1,304.51

  • RONW (%)

    5.53

  • ROCE (%)

    7.69

Score Board

  • Equity (₹ in Cr.)

    6.89

  • BV (₹)

    583.80

  • Sales( ₹ in Cr.)

    234.01

  • NP (in Cr.)

    15.80

  • NP Var(%)

    -42.0

  • Div%

    10.0

  • CPS (₹)

    35.10

  • EPS (₹)

    22.90

  • Traded Value (₹ in Lakhs)

    1,312.64

  • 52 Week High

    2,277.60

  • 52 Week Low

    1,125.70

  • Price BSE

    1905.0

  • Price NSE

    1,893.00

  • Market Capital( in Cr.)

    1,312.64

  • P/C Ratio

    54.30

  • P/E Ratio

    83.10

  • Price Vs.BV

    22.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 234.01 304.13 257.98 252.73 240.92 203.67
Excise Duty 0.00 0.00 0.00 34.75 28.91 0.00
Net Sales 234.01 304.13 257.98 217.98 212.01 203.67
Other Income 12.55 14.55 8.04 18.84 7.78 8.67
Stock Adjustments -2.05 -10.14 15.19 9.75 -1.68 -1.88
Total Income 244.51 308.54 281.21 246.57 218.11 210.46
EXPENDITURE :            
Raw Materials 149.90 179.46 173.71 147.23 134.39 132.16
Power and Fuel Cost 4.42 4.63 4.24 3.73 2.98 3.10
Employee Cost 25.13 21.38 19.62 16.93 15.26 14.39
Other Manufacturing Expenses 14.13 13.07 11.29 10.06 7.42 6.39
Selling and Administration Expenses 12.94 34.59 26.79 23.54 13.82 13.77
Miscellaneous Expenses 4.34 7.26 4.58 4.50 7.91 6.85
Employee Benefit Expenses 25.13 21.38 19.62 16.93 15.26 14.39
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 210.87 260.39 240.22 205.99 181.78 176.66
Operating Profit 33.65 48.16 41.00 40.59 36.34 33.81
Interest 3.44 4.79 3.80 2.57 1.31 0.76
Gross Profit 30.21 43.37 37.20 38.02 35.03 33.05
Depreciation 8.36 7.05 6.40 5.85 6.66 6.03
Profit Before Tax 21.85 36.32 30.80 32.17 28.37 27.02
Current Tax 6.96 10.58 8.66 8.40 8.01 7.09
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.13 -0.72 -0.45 -0.57 -0.94 -0.28
Reported Net Profit 16.02 26.45 22.59 24.34 21.30 20.21
Extraordinary Items 0.22 -0.71 -0.03 4.55 -0.53 0.16
Adjusted Net Profit 15.80 27.16 22.62 19.79 21.83 20.05
Adjustment below Net Profit 0.19 0.06 -0.20 0.04 -0.23 0.16
P & L Balance brought forward 231.09 205.16 183.19 158.81 137.74 117.37
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.69 0.58 0.43 0.00 0.00 0.00
P & L Balance carried down 246.60 231.09 205.16 183.19 158.81 137.74
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 7.50 0.00 0.00
Dividend Per Share(Rs) 1.00 1.00 1.00 0.75 0.00 0.00
Earnings Per Share-Unit Curr 23.24 38.38 38.82 42.14 36.89 35.27
Earnings Per Share(Adj)-Unit Curr 23.24 38.38 38.82 42.14 36.89 35.27
Book Value 583.78 561.27 367.05 330.86 287.72 251.22
Book Value(Adj)-Unit Curr 583.78 561.27 367.05 330.86 287.72 251.22

Shareholding Pattern

  • Promoter Group

    67.20%

  • Public Share Holding

    32.80%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 2,750,053 39.90 2,750,053 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,881,598 27.30 1,881,598 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,631,651 67.20 4,631,651 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 500 0.01 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 7,500 0.11 7,500 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 94,180 1.37 94,180 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,180 1.48 101,680 5
2] Non Institution
Bodies Corporate 567,311 8.23 221,781 43
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 254,998 3.70 248,498 51
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 57,513 0.83 54,313 86
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 350,994 5.09 350,994 5
Individuals holding nominal share capital up to Rs. 1 lakh 926,565 13.44 748,040 2,859
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 751 0.01 751 1
Others 0 0.00 0 0
Sub Total 2,158,132 31.31 1,624,377 3,045
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,891,963 100.00 6,357,708 3,059

Company Background

Bharat Parenterals LtdPharmaceuticals - Indian - Formulations

  • Bharat Parenterals Ltd
  • BSE Code : 3882.0
  • ISIN : INE365Y01019

  • Incorporation Year

    1992

  • Registered Office

    Survey No 144 & 146 Haripura
    Jarod Samlaya Road Tal Savli, Vadodara,
    Gujarat-391520

  • Telephone

    91-2667-251679

  • FAX

    91-2667-251670

  • Chairman

    Bharat Kumar R Desai

  • Managing Director

  • Company Secretary

    Sharmin Nareshkumar Soni

  • Auditor

    Shah Mehta & Bakshi

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Adroit Corporate Serv. Pvt Ltd
    205/206 Sterling Cen,
    R C Dutt Road ,Alkapuri
    Mumbai - Vadodara - 390007

Bharat Parenterals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Bharat Parenter. 1,904.60 246.57 234.01 135.66 5.74
Abbott India 25,629.80 7,217.19 6,929.05 33.73 43.78
Astrazeneca Phar 5,704.05 2,304.07 2,275.58 84.07 27.86
Glaxosmi. Pharma 2,534.65 3,932.76 3,790.20 40.49 58.17
Novartis India 1,986.40 393.10 354.33 50.16 15.94
Cipla 1,305.00 20,102.60 18,979.95 34.30 13.88
Bliss GVS Pharma 671.30 773.53 729.81 62.39 12.51
Fermenta Biotec. 537.85 474.15 450.25 25.11 18.77
Amrutanjan Healt 504.25 520.13 502.55 27.01 24.16
Guj. Themis Bio. 367.80 168.25 165.82 98.34 18.05
Ambalal Sarabhai 41.23 19.52 3.94 76.35 6.77